Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
149.27
-0.65 (-0.43%)
Official Closing Price
Updated: 7:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Johnson & Johnson
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area
September 20, 2022
From
Johnson & Johnson
Via
Business Wire
Oracle’s Short-Term Pain Could Be Your Long-Term Gain
September 20, 2022
Database and cloud solutions provider Oracle (NASDAQ: ORCL) stock got smoked on its fiscal Q1 2023 earnings report. Shares were holding up relatively
Via
MarketBeat
Johnson & Johnson Announces $5 Billion Share Repurchase Program
September 14, 2022
From
Johnson & Johnson
Via
Business Wire
OrPro Therapeutics Receives $2.147M Therapeutic Development Funding from US Department of Defense for COVID-19 and Influenza
July 19, 2022
Prestigious CDMRP award will advance development of ORP100S as an inhaled treatment for acute and chronic respiratory diseasesSAN DIEGO - July 19, 2022 - PRLog -- OrPro Therapeutics, Inc., a San Diego...
Via
PRLog
Topics
Derivatives
Exposures
COVID-19
Derivatives
Product Safety
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 13, 2022
From
Johnson & Johnson
Via
Business Wire
Monkeypox vaccine and research related stocks taking center stage (VRAX,GOVX,TNXP,APDN)
September 02, 2022
Via
AB Newswire
Exposures
COVID-19
aCommerce and Johnson & Johnson Launch Sustainable Packaging Solution for a Better E-commerce Future in the Philippines
September 01, 2022
Via
ACN Newswire
Worldwide Acne Treatment Market Is Projected to Reach About USD 8.69 Billion by 2028, with a CAGR of 5.1%
August 30, 2022
Acne Treatment Market SWOT Analysis Including Key Players Allergan plc, Almirall, S.A., Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK),...
Via
SBWire
Shock Absorbers: 3 Low Volatility Dividend Stocks for Bumpy Times
August 30, 2022
Low volatility dividend plays are built to show their worth over time. These three stocks have historically helped navigate investors through turbulent waters.
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company
August 24, 2022
From
Johnson & Johnson
Via
Business Wire
Agilis Consulting Group Appoints Former Johnson & Johnson Employee, Denise Wagner, as Principal Human Factors Consultant
August 11, 2022
Agilis is looking forward to continued growth with Denise as the Principal Consultant to help clients achieve their regulatory goals and create safer medical products for the end users.
Via
Newswire.com
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
August 10, 2022
Via
Investor Brand Network
Exposures
Product Safety
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
August 10, 2022
NetworkNewsWire Editorial Coverage New York, NY – August 10, 2022 – In medicine, there is a term called “clinical inertia,” or the case of what someone doesn’t know — or what they ignore — could kill...
Via
FinancialNewsMedia
Exposures
Product Safety
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
August 09, 2022
From
Johnson & Johnson
Via
Business Wire
Are Medtronic And Intuitive Surgical Poised For Big Growth?
August 09, 2022
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently.
Via
MarketBeat
Topics
ETFs
Exposures
COVID-19
Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
August 08, 2022
From
Johnson & Johnson
Via
Business Wire
Is Church & Dwight Co. Inc. (NYSE: CHD) a Buy for Dividend Investors?
August 05, 2022
Church & Dwight (NYSE: CHD) might not exactly be a household name, but you've likely heard of many of the company's brands: ARM & HAMMER, Trojan, First Response, Nair, Spinbrush, OxiClean, Orajel,...
Via
MarketBeat
Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference
August 02, 2022
From
Johnson & Johnson
Via
Business Wire
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease
July 26, 2022
Palm Beach, FL – July 26, 2022 – FinancialNewsMedia.com News Commentary – As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, concern it could...
Via
FinancialNewsMedia
Exposures
COVID-19
Product Safety
MarketBeat: Week in Review 7/18 – 7/22
July 22, 2022
Investors should be careful not to read too much into this week's rally. Next week will bring the Fed's decision on interest rates and key earnings reports from the tech sector. Both could cause...
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Supply Chain
Vaccines Market Expected to Witness a Sustainable Growth by 2032 - Future Market Insights, Inc.
July 20, 2022
FMI predicts vaccines market to reach a valuation of US $120B by 2032. Key Players - Merck & Co., Inc, GlaxoSmithKline, Pfizer BioNTech; Sanofi SA, CSL Limited, Emergent Biosolutions Inc., Johnson &...
Via
Newswire.com
Exposures
COVID-19
Healthcare Education Solutions Market Analysis, Size, Share, Trends, Global Industry Overview, Demand, Growth and Forecast 2028 Zimmer Biomet, Stryker, Medtronic, Canon Medical, Johnson & Johnson, FUJIFILM Holding, Olympus
July 19, 2022
Healthcare Education Solutions Market 2022 Industry Size, Share, Global Analysis, Growth, Development Status, Regional Trends, Opportunity Assessment and Comprehensive Research Study Forecast with...
Via
SBWire
Exposures
COVID-19
Johnson & Johnson Reports Q2 2022 Results
July 19, 2022
From
Johnson & Johnson
Via
Business Wire
Is it Time to Cash Out Novavax Stock?
July 19, 2022
Vaccine developer Novavax (NASDAQ: NVAX) stock has collapsed (-61%) in 2022. The Company’s protein-based COVID-19 vaccine Nuvaxovid has launched in Europe and awaits CDC approval for launch the U.S.
Via
MarketBeat
Exposures
COVID-19
Product Safety
Johnson & Johnson’s Executive Vice President, General Counsel Michael Ullmann to Retire; Elizabeth Forminard Named General Counsel, Effective October 17, 2022
July 18, 2022
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Continues to Prove its Value in a Volatile Year
July 17, 2022
Johnson & Johnson is scheduled to release its second quarter earnings report on July 19, 2022. Low single-digit growth may not do much to excite investors. But in this article, we’ll take a closer look...
Via
MarketBeat
Topics
Economy
Exposures
Economy
Cough Remedies Market 2022-2029 Global Industry Trends, Growth Rate and Revenue : Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis
June 30, 2022
Global Cough Remedies Market Research 2022-2031 published by Calibre Research studies the current situation, Cough Remedies market size, share, trends, regional growth and the latest technologies...
Via
SBWire
Topics
Supply Chain
Exposures
Supply Chain
Global Bio Implant Market 2022 Segment, Key Players Analysis and Forecast : Johnson & Johnson, Philips, Medtronic, C.R. Bard
June 30, 2022
Global Bio Implant Market Research 2022-2031 published by Calibre Research studies the current situation, Bio Implant market size, share, trends, regional growth and the latest technologies utilized by...
Via
SBWire
Topics
Supply Chain
Exposures
Supply Chain
Global Human Papillomavirus Vaccine Market 2022 Manufacturers Review, Status and Forecast 2029 : Merck, GlaxoSmithKline, Sanofi, AstraZeneca
June 30, 2022
Global Human Papillomavirus Vaccine Market Research 2022-2031 published by Calibre Research studies the current situation, Human Papillomavirus Vaccine market size, share, trends, regional growth and...
Via
SBWire
Topics
Supply Chain
Exposures
Supply Chain
Tigecycline Market Development Factors 2022-2029 Pfizer, Hisun Pharma, Hansoh Pharma, HICIN Pharma, Amgen
June 27, 2022
Global Tigecycline Market Research 2022-2031 published by Calibre Research studies the current situation, Tigecycline market size, share, trends, regional growth and the latest technologies utilized by...
Via
SBWire
Topics
Supply Chain
Exposures
Supply Chain
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.